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Abstract
Background: Hemangioblasts are known as the common precursors for primitive hematopoietic and endothelial
lineages. Their existence has been supported mainly by the observation that both cell types develop in close
proximity and by in vitro differentiation and genetic studies. However, more compelling evidence will arise from
tracking their cell fates using a lineage-specific marker.
Results: We report the identification of a hemangioblast-specific enhancer (Hb) located in the cis-regulatory region
of chick Cerberus gene (cCer) that is able to direct the expression of enhanced green fluorescent protein (eGFP) to
the precursors of yolk sac blood and endothelial cells in electroporated chick embryos. Moreover, we present the
Hb-eGFP reporter as a powerful live imaging tool for visualizing hemangioblast cell fate and blood island
morphogenesis.
Conclusions: We hereby introduce the Hb enhancer as a valuable resource for genetically targeting the
hemangioblast population as well as for studying the dynamics of vascular and blood cell development.
Background
In the early vertebrate embryo, both hematopoietic and
endothelial lineages derive from aggregates of mesoder-
mal cells that form the blood islands in the extraem-
bryonic yolk sac [1]. This observation led to the
hypothesis that both lineages derive from a common
precursor named the hemangioblast [2]. Although still
debatable, the existence of hemangioblasts is mainly
supported by in vitro differentiation studies [3,4] as well
as by evidence that blood and endothelial progenitors
express a number of genes in common, such as
VEGFR2, GATA2, Lmo2 and Scl/Tal1 [5], some of
which regulate the differentiation of both cell lineages
[6-8]. Other than these in vitro and genetic studies,
further insight into hemangioblast cell fate will require
time-lapse imaging studies using a lineage-specific
marker.
Hemangioblast reporters have been described in trans-
genic mouse and zebrafish models [9,10]. However, a
particularly suitable system for visualizing live hemato-
vascular development is the yolk sac of the avian
embryo [11,12]. During the study of chick Cerberus
(cCer) transcriptional regulation [13], we isolated a cis-
regulatory region that drives reporter gene expression
specifically in blood-island progenitors or hemangio-
blasts. Here, we report the identification and characteri-
zation of this novel hemangioblast-specific enhancer and
reveal its potential as a live imaging tool for studying
blood and vascular development.
Results and Discussion
To study the transcriptional activity of cCer cis-regula-
tory region, chick embryos were electroporated with
reporter constructs containing cCer 5’ genomic
sequences of different lengths upstream of the coding
sequence for enhanced green fluorescent protein
(eGFP), and observed under a fluorescent microscope
(Figures 1 and 2) [13]. Our initial results showed that a
400-base pairs (bp) promoter fragment upstream from
the ATG of cCer (Cer0.4) is able to drive eGFP expres-
sion in cell populations that express cCer, i.e., the ante-
rior mesendoderm (Figure 1) and the left-side
mesoderm [13,14]. Further deletion analysis revealed an
ectopic domain of expression in the posterior extraem-
bryonic mesoderm where hemangioblasts are located
[5]. This pattern was observed in embryos electropo-
rated with constructs that lack the -400 to -360 bp
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sequence (i.e., Cer0.36, PCR5 and PCR6; Figure 1), sug-
gesting that this region may contain a silencer of
hemangioblast expression. Cer-eGFP expression was
abolished in the anterior mesendoderm and restricted to
hemangioblasts in embryos electroporated with con-
structs that lack the -204 to -120 bp sequence (i.e.,
PCR2 and PCR8; Figure 1 and data not shown). PCR8
regulatory sequence is hereafter named the hemangio-
blast or Hb enhancer, and the hemangioblast-specific
reporters PCR2-eGFP and PCR8-eGFP are named Hb-
eGFP.
Sequence analysis of the Hb enhancer identified bind-
ing sites for transcription factors implicated in endothe-
lial and blood cell differentiation, namely ETS, GATA
and FoxH1 [15-17] (Figure 1A). To determine which of
these binding elements may be responsible for the regu-
lation of hemangioblast-specific expression, we analyzed
the expression of reporter constructs containing muta-
tions in the ETS (E), GATA (G1 and G2) or FoxH1 (F)
sites in the PCR8 sequence [17-19] (Figure 1A). Heman-
gioblast expression was unaltered in embryos electropo-
rated with the Emut, G1mut and Fmut constructs, but
abolished in those electroporated with the G2mut con-
struct (Figure 1B). These observations demonstrate that
the G2 site is essential for the induction or maintenance
of transcription in hemangioblasts, and suggest that the
GATA2 is a transcriptional activator of the Hb enhancer
in blood-island progenitors [5].
In the avian embryo, hemangioblasts ingress through
the posterior primitive streak between stages HH2 and
HH9 [20]. To characterize the expression pattern of the
Hb-eGFP reporter, embryos were electroporated at
either early or late stages (HH3-4 and HH5-6, respec-
tively), placed in culture and observed at successive time
points (HH4-13). In embryos electroporated at HH3-4,
Hb-eGFP fluorescence was initially detected in posterior
primitive streak cells (data not shown) and in a
cVEGFR2-positive population of posterior extraembryo-
nic cells (HH5; Figures 2A and 2B). At later stages,
eGFP-positive cells migrate away from the embryo and
form aggregates in the extraembryonic region (HH7;
Figure 2C) that will give rise to the blood islands (HH9;
Figure 2D). At HH11, Hb-eGFP fluorescence was
restricted to differentiated blood islands and the vascular
cells that connect them (Figure 2E and 2F). In embryos
electroporated at HH5-6, Hb-eGFP expression was spe-
cifically detected in the blood islands that form closer to
the embryo (Additional file 1). Taken together, these
observations suggest that the Hb enhancer is continually
activated in ingressing hemangioblasts that populate the
extraembryonic region in a lateral to medial temporal
progression [21].
Figure 1 Identification of the cCer hemangioblast enhancer. (A)
Enhancer analysis of the cCer cis-regulatory region. cCer 5’ genomic
sequences (black boxes) were either directly fused to the eGFP
reporter gene (green boxes) or sub-cloned into an enhancerless
vector carrying the human b-globin minimal promoter (dark blue
boxes) upstream of the eGFP coding sequence. Emut, G1mut,
G2mut and Smut constructs were designed by introducing
mutations in the ETS, GATA (G1 and G2) or FoxH1 (F) binding
elements of the PCR8 sequence, respectively (asterisks; see
sequence below). The presence ("+”) or absence ("-”) of eGFP
expression in the anterior mesendoderm (AM) and in
hemangioblasts (Hb) of electroporated chick embryos is listed on
the right. Each result is representative of at least 12 embryos. A
schematic representation of cCer -400 to -120 bp regulatory region
and the nucleotide sequence of the PCR8 fragment (-255 to -204
bp) are shown in the bottom. Binding sites for the transcription
factors ETS (E; blue), GATA (G1 and G2; green), FoxH1 (F; orange)
and Nkx-2.5 (yellow) are outlined. The ETS site in the -400 to -360
bp silencing region may be responsible for the repression of
hemangioblast expression, whereas the two Nkx-2.5 sites in the -204
to -120 bp sequence may regulate anterior mesendoderm
expression. Mutations introduced into the E, G1, G2 and F sites of
the Emut, G1mut, G2mut and Smut constructs are also indicated in
the PCR8 sequence. (B) Cer-eGFP reporter expression in
electroporated chick embryos. Embryos were co-transfected with
pCAGGS-RFP (positive control; red fluorescence) and each Cer-eGFP
reporter construct (green fluorescence) at stage HH3 and fixed at
HH6. Examples of electroporated embryos with ubiquitous RFP
fluorescence and specific eGFP expression in the AM (Cer0.4), AM
and Hb (PCR6), and Hb alone (PCR8), or without eGFP expression
(G2mut).
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Figure 2 Characterization of the Hb-eGFP-positive cell population. Chick embryos were processed for cVEGFR2 whole mount in situ
hybridization at HH5 (A) or co-electroporated at HH3-4 with the Hb-eGFP reporter construct (PCR2) and the ubiquitous reporter pCAGGS-RFP (B-
J) and imaged as whole mounts at HH5 (B), HH7 (C), HH9 (D) and HH11 (E), criosectioned through the yolk sac region at HH11 (F, H-J), or
processed for microarray analysis at HH5-6 (G). (B-D) Overlay of bright field, Hb-eGFP green fluorescence and RFP red fluorescence images. (E)
RFP fluorescence (left), Hb-eGFP fluorescence (middle) and overlay (right). (F, H-J) Top left: bright field and DAPI (F), bright field alone (H), or
bright field and RFP (in blue; I and J); top right: Hb-eGFP green fluorescence; bottom left: RFP red fluorescence (F) or immunolabeling of
cVEGFR2 (H), red blood cells (RBC; I) and smooth muscle actin (SMA; J); bottom right: overlay of bright field and fluorescence images. At HH5,
cVEGFR2 expression is detected in the posterior extraembryonic population of hemangioblasts (A). At this early stage, Hb-eGFP fluorescence is
specifically observed in the same cell population (B). At later stages, eGFP-fluorescent cells aggregate in the extraembryonic region (C), give rise
to blood islands (D), and integrate the vascular plexus of the yolk sac (E). Note that the control RFP reporter is ubiquitously expressed, whereas
Hb-eGFP fluorescence is restricted to the blood islands (E and F). At early stages, the gene expression profile of Hb-eGFP-positive cells revealed
that known hemangioblast markers are enriched, whereas genes expressed in other tissues are downregulated in this cell population (G; see also
Additional file 2). At later stages, Hb-eGFP fluorescence is detected in cVEGFR2-positive endothelial cells (H; arrow) and blood cells or
erythroblasts (I; arrows), but not in smooth muscle cells (J; arrowheads).
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To confirm the specificity of the Hb-eGFP reporter,
we analyzed the gene expression profile of early Hb-
eGFP-positive cells and investigated the co-localization
of eGFP fluorescence with known markers of hemangio-
blast-derived cells. As expected, genes expressed in
hemangioblasts, such as Lmo2 (+3.73 fold), Tal1 (+3.62
fold) and CD34 (+2.39 fold), are enriched in the Hb-
eGFP-positive population, whereas those expressed in
other cell types, such as the endoderm (e.g., Sox17),
neuroectoderm (e.g., Otx2) and paraxial mesoderm (e.g.,
Msgn1), are downregulated (Figure 2G; Additional file
2). At a later stage (HH11), Hb-eGFP fluorescence is
detected both in endothelial cells, which express
cVEGFR2 protein (Figure 2H), and in blood cells, which
express the RBC antigen (Figure 2I). However, Hb-eGFP
expression is not observed in the SMA-positive smooth
muscle cells that surround the blood islands (Figure 2J).
This observation supports the hypothesis that smooth
muscle cells are not derived from hemangioblasts [22].
Taken together, our observations indicate that Hb-
eGFP expression is initiated in hemangioblasts as they
emerge from the primitive streak and is detected in dif-
ferentiated endothelial and blood cells at least until
HH13 (data not shown). This pattern was confirmed by
time-lapse imaging of live electroporated embryos. At
low amplification, we could see the eGFP-fluorescent
cells moving away from the posterior primitive streak,
aggregating to form the blood islands, and giving rise to
the vascular plexus by connecting the separate islands
(Additional file 3). At higher magnification, we were
able to follow the movements of individual endothelial
and blood cells (Additional file 4), such as the inter-
change of cells between different blood islands and the
cell division of an erythroblast. Moreover, in older
embryos, the Hb-eGFP reporter proved to be a very use-
ful tool to record blood cell flow in the vascular plexus
of the yolk sac (Additional file 5).
Conclusions
In summary, we identified a hemangioblast enhancer
located in cCer cis-regulatory region and describe its
activity in developing chick embryos. Furthermore, we
have used the Hb-eGFP reporter to characterize the
gene expression profile of hemangioblasts and visualize
blood island morphogenesis and differentiation in living
embryos. In the future, the Hb-eGFP reporter may
become a valuable genetic tool for targeting ectopic
gene expression to the hemangioblast population as well
as for studying live vasculogenesis and blood flow.
Methods
DNA constructs
The isolation and cloning of cCer 5’ genomic sequences
was performed as previously reported [13]. In particular,
cCer regulatory sequences were amplified by PCR using
the Cer0.36-eGFP construct DNA as template (primer
sequences provided upon request), and sub-cloned into
the SacI/SpeI restriction sites of the p1229-eGFP enhan-
cerless vector, which carries the human beta-globin
minimal promoter [23] upstream of the eGFP coding
sequence (Clontech). Putative binding elements for ETS,
GATA (sites 1 and 2) and FoxH1 transcription factors
were identified in the analysis of cCer genomic
sequences using MatInspector Professional release 7.4
[24] and MatchTM [25]http://www.gene-regulation.
com/. Mutations in these elements were designed
according to the literature [18,19,26] and introduced
into the PCR8 construct by PCR-based site-directed
mutagenesis. The pCAGGS-RFP vector (gift from D.
Henrique), which contains the CAGGS promoter and
the cDNA of monomeric red fluorescent protein (RFP;
Clontech) [27] was used to control the electroporation
efficiency.
Embryo electroporation and imaging
Chicken embryos were explanted and electroporated at
stages HH3-5 [28] as described previously [13]. Electro-
porated embryos were grown in New culture [29] until
stages HH6-11, observed under a Zeiss SteREO Lumar
fluorescence stereomicroscope (Carl Zeiss) and photo-
graphed using a Hamamatsu C8484 digital camera
(Hamamatsu Photonics) and AxioVision software (Carl
Zeiss).
Fluorescence-activated cell sorting (FACS)
Chicken embryos were electroporated at HH3 with Hb-
eGFP and pCAGGS-RFP constructs, harvested at stage
HH5-6 into three groups of four embryos each, disso-
ciated into single cell suspensions using trypsin (Sigma-
Aldrich) and filtered through a 35 μm cell strainer (BD
Bioscience). The eGFP+ and eGFP-/RFP+ cell popula-
tions were FACS-sorted in a Moflo high-speed cell sor-
ter (Beckman Coulter), using a 70 μm ceramic nozzle
with 0.414MPa (60 psi) sheath pressure, a 488 nm laser
line from a Coherent Sapphire 488-200 CDRH laser for
eGFP excitation, and a 561 nm laser line from a Crys-
taLaser GCL-050-561 50 mW DPSS laser coupled to
fiber optics (38 mW output) to excite RFP. eGFP+ and
RFP+ cells were detected using 530/40 nm and 630/75
nm HQ band pass filters, respectively, and collected
simultaneously into two different tubes containing RNA-
later (Ambion).
RNA Isolation and Microarray Expression Analysis
Total RNA was extracted from triplicates of each cell
population using the RNeasy Mini Kit (Qiagen). Con-
centration and purity was determined by spectrophoto-
metry and integrity confirmed using an Agilent 2100
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Bioanalyzer with a RNA 6000 Nano Assay (Agilent
Technologies). Prior to processing for microarray hybri-
dization, RNA samples from FACS-sorted eGFP+ and
eGFP-/RFP+ populations were analyzed for the expres-
sion of control and marker genes (GAPDH, eGFP, RFP,
cVEGFR2, cLmo2 and cBra) by reverse transcription
polymerase chain reaction (data not shown). For each of
the six samples, 40 ng of total RNA was processed
according to the manufacturer’s Two-Cycle Target
Labeling Assay. Size distribution of the cRNA was
assessed using an Agilent 2100 Bioanalyzer with a RNA
6000 Nano Assay. Affymetrix GeneChip Chicken Gen-
ome Arrays were hybridized at 45°C for 16 h with 15 μg
of fragmented cRNA, washed and double-stained on an
Affymetrix GeneChip Fluidics Station 450, and scanned
on an Affymetrix GeneChip scanner 3000 7G. The
arrays were analyzed using Affymetrix GCOS 1.4 and
dChip 2008 software (http://www.dchip.org, Wong Lab,
Harvard). Normalized CEL intensities of the six arrays
were used to obtain gene expression indices based on a
Perfect Match-only model. Only genes with a lower 90%
confidence bound of the fold change above 1.7 were
regard as differentially expressed and used for further
analysis. Annotations for the 33.457 transcripts that are
represented on the GeneChip Chicken Genome Array
were obtained from the NetAffx database http://www.
affymetrix.com as of September 2008. Out of this total
number of transcripts, 658 were differentially expressed
in the two populations, including 476 known genes (fold
change > 1.7). Of these, 170 were upregulated and 306
downregulated in Hb-eGFP+ cells. Microarray data have
been deposited in NCBI’s Gene Expression Omnibus
(GEO) with the accession number GSE32494.
In situ hybridization and Immunohistochemistry
Whole-mount in situ hybridization was performed as
described previously [14]. The cVegfr2 riboprobe frag-
ment (nucleotides 2488-2771) was generated by RT-PCR
and cloned into pGEMTeasy vector (Promega). Embryo
images were acquired using a Leica MZ FLIII stereomi-
croscope, a Leica DFC420C digital camera (Leica Micro-
systems) and IrfanView software http://www.irfanview.
com/.
For immunohistochemistry, electroporated embryos
were fixed in 4% paraformaldehyde, cryoprotected in
15% sucrose, embedded in 7.5% gelatine/15% sucrose
and cryosectioned at 16 or 20 μm. Immunostaining was
performed using primary antibodies against avian
VEGFR2 (gift from Anne Eichmann) [3], chicken Red
Blood Cells (RBC; #103-4139; Rockland Immunochem-
icals), and alpha smooth muscle actin (SMA; #ab5694;
Abcam), and secondary antibodies labeled with the
fluorescent probe Alexa Fluor 568 (#A11004; Molecular
Probes/Invitrogen) or Alexa Fluor 647 (#A21245;
Molecular Probes). Cell nuclei were labeled with 4’, 6-
diamidino-2-phenylindole (DAPI; Molecular Probes).
Sections were mounted in Fluorescence Mounting Med-
ium (Dako), photographed using either a Leica DMRA2
fluorescence microscope with a HC PL Fluotar 20/0.50
objective (Leica Microsystems), Photometrics CoolSNAP
HQ camera (Photometrics) and MetaMorph software
(Molecular Devices; Figures 2F, Additional file 1B and
1C), or a Leica TCS SP5 confocal microscope with a
HCX PL Apo CS 40/1.40-0.60 objective and Leica
Application Suite software (Leica Microsystems; Figures
2H-J). Images were processed and assembled using
Photoshop CS3 (Adobe Systems) and Imaris (Bitplane).
Additional material
Additional file 1: Hb-eGFP expression in chick embryos
electroporated at late stages. Chick embryos were co-electroporated
with Hb-eGFP (PCR2) and pCAGGS-RFP reporter constructs at HH5 and
fixed at HH11. Top left: bright field (BF); top right: Hb-eGFP green
fluorescence; bottom left: RFP red fluorescence; bottom right: overlay of
bright field and fluorescence images. Hb-eGFP expression is detected in
blood islands (arrows) and in the vascular plexus of the area pellucida
(arrowhead).
Additional file 2: List of selected genes up- and down-regulated in
Hb-eGFP+ cells at HH5-6. Listed genes exhibit greater than 1.7-fold
change (lower bound) in expression in Hb-eGFP+ versus Hb-eGFP- cells.
Gene function and expression patterns are given when known and were
obtained from GEISHA http://geisha.arizona.edu/geisha and from the
literature.
Additional file 3: Time-lapse movie of a developing chick embryo
co-electroporated with Hb-eGFP (PCR2) and pCAGGS-RFP reporter
constructs (stages HH4 to HH11). As the embryo elongates, Hb-eGFP-
positive cells move away from the primitive streak, aggregate to form
the blood islands, and give rise to the vascular plexus by connecting the
separate islands. Anterior side of the embryo is to the top; images were
taken under a Leica DMIRE2 inverted microscope (2.5 × objective; green,
Hb-e GFP; red, RFP); 6 min per frame; total time = 24 hours and 12 min;
time is indicated in hours in the upper left corner of the image.
Additional file 4: Time-lapse movie of yolk sac blood islands. The
chick embryo was co-electroporated with Hb-eGFP (PCR2) and pCAGGS-
RFP reporter constructs at stage HH4 and imaged from HH10 to HH11.
eGFP-positive cells are found in blood islands as well as in the vascular-
like structures that connect individual blood islands. In this video, we
could identify individual cells moving between different blood islands
(white arrowhead) as well as the division of a hematopoietic cell in one
of the blood islands (yellow arrowheads). Images were taken under a
Leica Sp5 confocal microscope (10 × objective; green, Hb-eGFP; red, RFP;
small square = 50 mm); 3 min per frame; total time = 4 hours and 6
min; time is indicated in hours in the upper left corner of the image.
Additional file 5: Time-lapse movie of blood cell flow in the yolk
sac. The chick embryo was co-electroporated with Hb-eGFP (PCR8) and
pCAGGS-RFP reporter constructs at stage HH4- and imaged at HH12. At
this stage, movements of eGFP fluorescent blood cells are already
observed within the vascular plexus of the yolk sac. Images were taken
under a Leica Sp5 confocal microscope (10 × objective; green, Hb-e GFP;
red, RFP); 3 min per frame; total time = 75 min; time is indicated in
minutes in the upper left corner of the image.
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